Strategy Detail

Adaptive SOXL Sleeve

Adaptive SOXL overlay candidate for research and paper-trading review.

Equities Leveraged ETF Risk: Very Aggressive Status: Paper Candidate Updated 2026-05-11

paper soxl semiconductors

Review Strategy Paper Candidate Read the thesis, stock universe, risk profile, and evidence notes. Performance Area Safe Preview Shows stored research metrics only. No fake live performance is displayed. Attach Strategy Beta Intent Starts the beta-safe stock attachment intent flow for this strategy. Portfolio Stock Accounts Review stock account attachment status and next steps.

Beta Strategy Dashboard

Stock strategy snapshot

Equities Asset ScopeBeta users only see stock strategy workflows.

Very Aggressive Risk ProfileVery aggressive leveraged ETF sleeve with high volatility and compounding decay risk.

Stock universe not specified yet Stock UniverseUniverse shown from stored strategy metadata.

Provider not live Brokerage StateNo attachment intent yet. Attach Strategy.

Performance areas show stored research/backtest fields when available. If provider-backed data is missing, the beta intentionally shows placeholders instead of fake live performance.

Evidence Freshness

Stale After Edit

The strategy metadata was updated after the attached backtest period ended. The result can still be explored, but it needs a refresh before publishing confidence.

Demo Demo 12 monthly rows

Test period2025-04-24 to 2026-04-23

Data sourceOmnimint Demo Fixture | Demo

Last refreshed2026-05-11

MethodologyReview assumptions

Fees Not stored in summary Use trade-level imports with fee fields before presenting net-of-fee confidence.

Slippage Not stored in summary Backtest readers should assume slippage is unknown unless the source report states it.

Dividends Provider adjusted if available The app should label dividend handling explicitly when imported data exposes it.

Splits Provider adjusted if available Reverse-split and split-adjustment checks should be called out before publication.

Benchmark Not attached Benchmark comparison is shown as a placeholder until a benchmark series is imported.

Research Decision Path

A simple way to read this strategy.

Use this page to move from thesis to evidence to context, then decide whether the strategy deserves a save, follow, or subscription preview. Nothing on this page authorizes broker access, deployment, or orders.

Step 1 Review stock fit Confirm the strategy is stock-focused and matches the beta account path.

Step 2 Inspect risk Use drawdown, exposure, and risk labels as research context only.

Step 3 Check attachment state Confirm whether a stock brokerage attachment preference exists.

Step 4 Continue beta setup Move to the Portfolio brokerage attachment shell when ready.

Related Context

Do not judge it alone.

Before a user trusts a strategy, they should be able to compare it, inspect the creator, and understand the market setting around it.

Strategy Search Stock strategies Return to the beta stock strategy catalog. Portfolio Stock account setup View selected stock account types and attachment status. Brokerage Attach this strategy Save a provider-pending attachment intent for this selected strategy. Account Beta account basics Review account and session state before inviting testers.

Strategy Profile

Type: leveraged-etf | Asset class: equities | Status: paper_candidate | Visibility: private

Latest version: v1 | manual-create | Total snapshots: 1

Methodology preview: Full methodology details are available to viewers with premium research access.

Risk disclosure: Very aggressive leveraged ETF sleeve with high volatility and compounding decay risk.

Creator

OmniMint Lab verified

Internal research profile for local application demos and review workflows.

equities risk-review strategy-research

Premium Research Locked

free Public visitor can view only free strategy preview content.

Subscribe or receive an approved content entitlement to unlock the full methodology notes, version notes, and research evidence. Subscription access is research-only and does not grant broker permissions.

Premium research is locked for this view. Unlocking it requires an active content entitlement and still does not authorize broker access, deployment, or trading.

Locked Full methodologyRequires strategy:premium_content.

Locked Version notesPremium source snapshot notes are hidden in this view.

Locked Evidence notesDetailed evidence commentary requires content access.

Still blocked Broker permissionsContent access does not grant trading permissions.

Performance KPI Strip

Performance Snapshot

These metrics summarize the attached backtest only. Missing metrics are labeled unavailable or partial instead of being estimated from private or unavailable data.

Return 125.00% Available

Total historical return for the attached backtest period.

Max Drawdown 18.20% Available

Largest historical peak-to-trough loss shown by this backtest.

Volatility 12.01% Available

Monthly PnL volatility proxy. Marked partial until at least 12 monthly observations are attached.

Sharpe-Like 1.58 Available

Risk-adjusted score imported with the backtest when available.

Win Rate Not stored Unavailable

Trade-level wins and losses are not in this strategy detail payload yet.

Exposure Not stored Unavailable

Target portfolio exposure is not stored in marketplace strategy metadata yet.

Backtest Period 2025-04-24 to 2026-04-23 Stale

Marked stale when the strategy was updated after the attached backtest period ended.

Backtest Chart States

Historical curve, not a promise.

These chart states make the report readable while clearly labeling missing benchmark, drawdown-curve, and allocation data.

Range: 2025-04-24 to 2026-04-23 Source: Omnimint Demo Fixture Preview ending value: $225,300.00

05 $11,800.00

06 $-7,400.00

07 $23,800.00

08 $9,200.00

09 $-9,800.00

10 $18,400.00

11 $12,600.00

12 $15,200.00

01 $-6,100.00

02 $20,100.00

03 $25,100.00

04 $12,400.00

Equity Curve Ready Uses starting equity plus attached monthly PnL rows.

Drawdown Ready Shows imported max drawdown now; full drawdown curve needs daily equity points.

Benchmark Comparison Placeholder Benchmark series is not attached yet, so the UI labels this instead of guessing.

Monthly Returns Ready Bars support hover copy and positive/negative visual states.

Allocation Over Time Placeholder Allocation history requires trade-level allocation or portfolio snapshots.

Chart interactions are review states only. Historical curves can explain what happened, but they do not imply future returns.

Trade History & Export

Inspect behavior before trusting the headline.

Trade rows show date, symbol, action, allocation, price, PnL, reason, and confidence where imported. Missing rows are labeled instead of hidden.

Disabled | research-only export placeholder

Date	Symbol	Action	Allocation	Price	PnL	Reason	Confidence
Trade detail locked.Trade-level research evidence requires premium content access.

Exports are intentionally disabled until permission, entitlement, and data-completeness states are explicit.

OmniScore Explanation Panel

How To Read OmniScore

OmniScore is a structured review score, not a signal. It combines return, drawdown, consistency, volatility-aware quality, evidence quality, and fit context so users can compare research with more skepticism.

Return 25.0/25 Available | 0-25

Rewards historical return, but does not override drawdown or evidence quality.

Total return was 125.00%.

Drawdown 13.6/25 Available | 0-25

Rewards strategies that produced returns without extreme historical drawdowns.

Max drawdown was 18.20%.

Consistency 15.4/20 Available | 0-20

Uses monthly evidence where available. Fewer than 12 months lowers confidence.

Positive-month rate was 69.23% across 13 periods.

Volatility 17.5/20 Low Confidence | 0-20

Uses risk-adjusted quality as a volatility-aware proxy. Missing Sharpe lowers confidence.

Sharpe was 1.58; return/drawdown ratio was 6.87.

Evidence Quality 4.0/10 Low Confidence | 0-10

Rewards complete metadata, enough trades, monthly observations, and non-demo evidence.

Evidence=demo, sample=demo, data_source=omnimint_demo_fixture, trades=91, monthly periods=13.

Fit Category Equities / Very Aggressive Available | Context

Shows the strategy family and risk band OmniMint users should understand before comparing it.

Shows the strategy family and risk band OmniMint users should understand before comparing it.

OmniScore is not a recommendation to buy, sell, subscribe, or deploy. It is a review score for comparing evidence quality and risk context.

Risk Explanation Panels

Understand The Uncomfortable Parts

These panels translate risk language into plain English before a user follows, subscribes, or requests any future review workflow. They are educational and not personalized investment advice.

Moderate drawdown

Drawdown

The attached evidence shows a max drawdown of 18.20%.

Example: A 20% drawdown means a historical $10,000 research allocation would have fallen near $8,000 before recovering. Warning: Drawdown can be worse in future markets, especially with gaps, slippage, or regime changes.

Volatility reviewed

Volatility

Monthly PnL volatility proxy is 12.01% from 12 monthly observations.

Example: A high-volatility strategy can move sharply even when the final backtest return looks attractive. Warning: Volatility is not timing advice; it is a reason to inspect position sizing and holding-period risk.

Leveraged exposure

Leverage

The strategy copy contains leveraged-product markers.

Example: Leveraged ETFs can compound losses quickly and may not track long-term index returns one-for-one. Warning: Leverage suitability depends on separate customer context and must not be assumed from this page.

Concentrated theme

Concentration

The strategy appears tied to a sector, theme, or narrow symbol set.

Example: A semiconductor-focused strategy can be hit by the same earnings, export-control, or demand-cycle shock across several holdings. Warning: Concentration can make several positions fail together even when they look diversified by ticker.

No inverse marker

Inverse Exposure

No obvious inverse or volatility-product marker was detected in public metadata.

Example: Inverse and volatility-linked products can decay, rebalance, or behave differently from a simple short position. Warning: Inverse exposure should be reviewed separately from normal long-only equity risk.

High

Regime Sensitivity

The strategy logic may depend on trend, breakout, mean-reversion, or volatility regimes.

Example: A breakout system can look strong in trending markets and struggle when prices chop sideways. Warning: Regime notes are educational and are not personalized investment advice.

Composer Import Validation

not_available 0 warnings | 0 nodes | 0 tickers | 0 unsupported steps

Recognized tickers: -

Recognized steps: -

Severity	Code	Path	Message
No Composer validation warnings.

Validation is advisory only. It reviews imported JSON structure and metadata, but it does not edit strategy logic, connect brokers, place orders, or deploy traders.

Paper Review

blocked

demo backtests are not review-grade evidence

Public Listing

blocked

visibility must be public; demo backtests are not public-listing evidence

Latest Backtest

$100,000.00 Starting Equity

$225,000.00 Ending Equity

91 Trades

demo Source

demo Evidence Type

demo Sample Label

omnimint_demo_fixture Data Source

OmniScore Components

25.0/25 Return Total return was 125.00%.

13.6/25 Drawdown Control Max drawdown was 18.20%.

15.4/20 Consistency Positive-month rate was 69.23% across 13 periods.

17.5/20 Risk-Adjusted Quality Sharpe was 1.58; return/drawdown ratio was 6.87.

4.0/10 Evidence Quality Evidence=demo, sample=demo, data_source=omnimint_demo_fixture, trades=91, monthly periods=13.

Overfit & Risk Diagnostics

high High-risk diagnostics found. Strengthen evidence before promotion.

Severity	Check	Finding	Follow-up
info	sample_length	Backtest sample length looks reviewable.	-
info	trade_count	Trade count is sufficient for first-pass review.	-
warning	drawdown	Drawdown is meaningful relative to many customer comfort bands.	Add clearer risk disclosure and compare lower-risk variants.
info	month_concentration	Profit is not overly concentrated in the best month.	-
warning	parameter_sensitivity	No parameter sensitivity evidence is attached to the strategy record.	Draft an experiment that changes one parameter at a time.
high	evidence_type	Evidence type is demo, which is weak for promotion.	Replace with verified local, walk-forward, paper, or broker-history evidence.
warning	out_of_sample_gap	No out-of-sample, walk-forward, holdout, paper, or live sample label is attached.	Add a clearly labeled validation slice before promotion.
info	risk_controls	Strategy metadata includes at least one risk-control reference.	Confirm the control is reflected in the executable source before promotion.

Diagnostics are deterministic review notes only. They can suggest follow-up experiments, but they do not tune, deploy, or trade a strategy.

Optimization Preview

Ideas are suspects until tested.

Each card separates the hypothesis, likely tradeoff, affected parameter area, and evidence baseline before anyone trusts the suggestion.

Not Started 2

Running 0

Complete 0

Failed 0

Rejected 0

Not Started

Suggestion #1 | high

Evidence

Hypothesis: Replace demo results with a verified local backtest artifact before using this score for review.

Expected tradeoff: Potential improvement must be tested one variable at a time to avoid overfitting.

Affected parameters: Evidence one-variable research test.

Evidence summary: 125.00% return, 18.20% drawdown, 91 trades

Not Started

Suggestion #2 | low

Robustness

Hypothesis: Strong return profile: prioritize out-of-sample, split-adjustment, and parameter sensitivity checks before adding complexity.

Expected tradeoff: May increase confidence but can expose that the original result was overfit.

Affected parameters: Robustness one-variable research test.

Evidence summary: 125.00% return, 18.20% drawdown, 91 trades

Optimization can overfit. Treat every suggestion as a proposed research experiment only; this UI does not edit real strategies, rerun traders, or change schedules.

OmniScore Suggestions

Each action drafts a proposed research experiment only. Human review is still required before testing, attaching results, or changing any lifecycle state.

#	Priority	Area	Suggestion	Action
#1	high	Evidence	Replace demo results with a verified local backtest artifact before using this score for review.	Draft research experimentPOST /api/experiments/from-suggestion {"created_by": "local-user", "source_backtest_id": "demo_bt_demo_soxl_adaptive", "suggestion_index": 1}
#2	low	Robustness	Strong return profile: prioritize out-of-sample, split-adjustment, and parameter sensitivity checks before adding complexity.	Draft research experimentPOST /api/experiments/from-suggestion {"created_by": "local-user", "source_backtest_id": "demo_bt_demo_soxl_adaptive", "suggestion_index": 2}

Backtest History

Backtest	Period	Return	Drawdown	Evidence	Source
demo_bt_demo_soxl_adaptive	2025-04-24 to 2026-04-23	125.00%	18.20%	demo demo	demo

Optimization Experiments

Experiment	Status	Focus	Source Suggestion	Result
No optimization experiments recorded yet.

Execution guardrail: this strategy detail page is analytics and review only. It does not connect brokers, place orders, change schedules, or deploy traders.